From ANABOLICS 2009 (William Llewellyn) pg260
Halodrol (chlorodehydromethylandrostenediol)
Chlorodehydromethylandrostenediol (COMA) is an oral anabolic steroid derived from testosterone. It is extremely close in structure to chlorodehydromethyltestosterone (Oral Turinabol), differing only by the substitution of the basic steroid 3-keto group with a 3-hydroxyl.lt is essentially aIIdiol" form of Oral Turinabol, and with this understanding is often described as aIIprohormone"orIIprosteroid" to this well-known and highly valued anabolic steroid. While some conversion to active chlorodehydromethyltestosterone is assumed, based on its structure it is likely that this conversion is far from complete, and that much of the anabolic and androgenic activity received with use is intrinsic to COMA. This steroid is non-aromatizable, and exhibits a greater tendency for anabolic as compared to androgenic effect.
History:
Chlorodehydromethylandrostenediol was first described in 2005, when it was introduced to the u.s. supplement market as a IIprosteroid" by Gaspari Nutrition. The agent was considered aIIgrey market" product, containing a drug that was not technically illegal due to' it not being specifically listed in previous controlled substance laws. The designation of nutritional supplement, however, was viewed as highly controversial. In November 2005, Halodrol was the subject of a scathing article in the Washington Post for its unrestricted and likely illegal OTC sale.562 Don Catlin of the UCLA Olympic Analytical Laboratory analyzed the product for the Post, and described Halodrol as containing, lIa steroid that closely resembles Oral-Turinabol, the principal steroid used to fuel East Germany's secret, systematic sports doping program." Catlin also claimed that the product contained desoxymethytestosterone (Madol), something the manufacturer has denied.
-------------------------------------
It's been a prosteroid from the start (2005).
